Armata Pharmaceuticals, Inc. — Director's Dealing 2020

Feb 14, 2020

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Armata Pharmaceuticals, Inc. (ARMP)
CIK: 0000921114
Period of Report: 2019-12-31

Reporting Person: COOK JEREMY CURNOCK (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-09	Warrant to Purchase Common Stock	$0.3223	J	46666	Disposed	2021-11-22	Common Stock (46666)	Indirect

Footnotes

F1: The reported securities were redeemed by the issuer for $12,065.46.

F2: The number of shares of common stock for which the warrant was exercisable does not reflect the 1-for-14 reverse stock split that was effected on May 9, 2019.

F3: The warrant was held by One Funds Management Limited as Trustee for Asia Pacific Healthcare Fund II ("One Funds Management"). The Reporting Person may be deemed to have shared voting and dispositive power over the shares beneficially owned by One Funds Management but disclaims such beneficial ownership, except to the extent of his pecuniary interest therein, if any.

F4: Price reported is reflective of adjustments made after the date of issuance pursuant the terms of the warrant.